You are here

Share:

Search Technologies

Showing 1-2 of 2 results found

Leucine Zipper-bearing Kinase (LZK) -Targeting Degraders and Methods of Use

The National Cancer Institute (NCI) seeks research co-development partners and/or licensees for Leucine Zipper-bearing Kinase (LZK) -targeting proteolysis-targeting chimeras (PROTACs) as a therapeutic for treating head and neck, lung and ovarian squamous cell carcinoma, as well as small cell lung cancers which over-express LZK.